Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
enzalutamide
×
Tumor-Agnostic
×
Clear all
Filters
3
NCT03314324
2025-04-17
ODENZA
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
Completed
250 enrolled
NCT03295565
2022-04-15
OSTRICh
The Netherlands Cancer Institute
Phase 2/3
Completed
100 enrolled